Results 91 to 100 of about 43,829 (215)

Newer vaccines (measles-rubella, human papillomavirus, rotavirus, and pneumococcal conjugate vaccine) introduction: Experience from Northern India

International Journal of Noncommunicable Diseases, 2018
Vaccines are essential to ensure that the population is immune to certain diseases, and immunization is one of the most cost-effective interventions to prevent the occurrence of the diseases.
Madhu Gupta, Kanica Kaushal, Nikita Sharma, Atul Gupta, Abu Mohammad Bashar, Suresh Dalpath, Shivani Gupta, G B Singh   +7 more
doaj   +1 more source

Deficits in Long-Term Vaccine Immunity Among Childhood Cancer Survivors Despite Revaccination Programs

Vaccines
Background: Childhood cancer survivors (CCSs) often experience impaired humoral immunity because of cancer treatments that increase their susceptibility to vaccine-preventable diseases. This study aimed to assess the seroprevalence of tetanus and rubella
Alexander Zadruzny, Eva Tiselius, Tiia Lepp, Teodora Aktas, Teghesti Tecleab, Samuel Hellman, Maja Jahnmatz, Anna Nilsson   +7 more
doaj   +1 more source

Anatomy of a Health Scare: Education, Income and the MMR Controversy in the UK [PDF]

One theory for why there is an education gradient in health outcomes is that more educated individuals more quickly absorb new health-related information.
Arnaud Chevalier, Dan Anderberg, Jonathan Wadsworth   +2 more
core  

Duration of Immunity After Rubella Vaccination: A Long-Term Study in Switzerland [PDF]

, 2017
In Switzerland 319 of 594 young women seronegative for rubella antibody vaccinated at 15-25 years of age against rubella with the Cendehill vaccine strain were retested 15 years later with three tests (hemagglutination inhibition, enzyme-linked ...
Berger, Rosemarie, Burkhardt, Felix, Just, Max, Just, Vroni, Schilt, Ueli   +4 more
core  

On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000–2023, Namibia

Vaccines
Introduction: The WHO Measles and Rubella Strategic Framework 2021–2030 within the Immunization Agenda 2030 includes both measles and rubella elimination goals and provides guidance to countries for planning and implementing the measles and rubella ...
Balcha G. Masresha, Messeret E. Shibeshi, Roselina de Wee, Nicholas Shapumba, Takudzwa Sayi, Susan E. Reef, James L. Goodson   +6 more
doaj   +1 more source

The Update, March 22, 2010 [PDF]

, 2010
The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...

core  

Rubella Antibody Levels in School-Aged Children in Newfoundland: Implications for a Two-Dose Rubella Vaccination Strategy

Canadian Journal of Infectious Diseases, 1997
OBJECTIVE: To determine the prevailing levels of rubella immunity among school-aged children who received a single dose of measles-mumps-rubella (MMR) vaccine at one year of age.
Samuel Ratnam, Roy West, Veeresh Gadag, Brett Williams, Elizabeth Oates   +4 more
doaj   +1 more source

The Impact of Childhood Health on Adult Educational Attainment: Evidence from Modern Mandatory School Vaccination Laws [PDF]

This paper examines the impact of post-neonatal childhood health on adult educational attainment using evidence from mandatory school vaccination laws in the U.S.
Dara N. Lee
core  

Study on the performance enhancement of biomedical implants: in vitro test under UV irradiation of titanium anodised in mixed electrolyte [PDF]

, 2018
Titanium (Ti) recently has widely been used in the biomedical applications due to its high performance. Therefore, surface modifications of titanium have attracted a lot of interest to provide better osseointegration.
Elfallah, Saleh S Saleh
core  

Accelerating Global Measles and Rubella Eradication—Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic

Vaccines
No vaccine has been more effective in reducing disease burden, especially in preventing child deaths, than measles-containing vaccine. The return on investment makes measles-containing vaccine one of the most cost-effective public health measures ...
David N. Durrheim, Jon K. Andrus, Shahina Tabassum, David Githanga, Mira Kojouharova, Nadia Talab   +5 more
doaj   +1 more source